Authors: Skarlos, DV Samantas, E Briassoulis, E Panoussaki, E Pavlidis, N Kalofonos, HP Kardamakis, D Tsiakopoulos, E Kosmidis, P Tsavdaridis, D Tzitzikas, J Tsekeris, P Kouvatseas, G Zamboglou, N Fountzilas, G

Citation: Dv. Skarlos et al., Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: A randomized phase II study of the Hellenic Cooperative Oncology Group (HeCOG), ANN ONCOL, 12(9), 2001, pp. 1231-1238

Authors: Christodoulou, C Bafaloukos, D Kosmidis, P Samantas, E Bamias, A Papakostas, P Karabelis, A Bacoyiannis, C Skarlos, DV

Citation: C. Christodoulou et al., Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases, ANN ONCOL, 12(2), 2001, pp. 249-254

Authors: Aravantinos, G Dimopoulos, MA Kosmidis, P Bafaloukos, D Papadimitriou, C Kiamouris, C Pavlidis, N Sikiotis, K Papakostas, P Skarlos, DV

Citation: G. Aravantinos et al., Ifosfamide plus oral etoposide salvage chemotherapy for platinum-resistantpaclitaxel-pretreated ovarian cancer, ANN ONCOL, 11(5), 2000, pp. 607-612

Authors: Aravantinos, G Skarlos, DV Kosmidis, P Georgoulias, V Sgouros, I Bafaloukos, D Androulakis, N Florou, S Fountzilas, G

Citation: G. Aravantinos et al., Irinotecan (CPT-11) in patients with advanced colorectal cancer previouslytreated with 5-fluorouracil-based chemotherapy, CR R ONC H, 32(3), 1999, pp. 209-219

Authors: Skarlos, DV Samantas, E Pectasides, D Pavlidis, N Kalofonos, C Klouvas, G Panoussaki, E Tsiakopoulos, E Poulakis, N Fountzilas, G

Citation: Dv. Skarlos et al., Weekly alternating non-cross-resistant chemotherapy for small cell lung cancer with a good prognosis - A study of the Hellenic Cooperative Oncology Group, AM J CL ONC, 22(1), 1999, pp. 87-93

Authors: Samantas, E Skarlos, DV Pectasides, D Nicolaides, P Kalofonos, H Mylonakis, N Vardoulakis, T Kosmidis, P Pavlidis, N Fountzilas, G

Citation: E. Samantas et al., Combination chemotherapy with low doses of weekly Carboplatin and oral Etoposide in poor risk small cell lung cancer, LUNG CANC, 23(2), 1999, pp. 159-168